The comparable tumour microenvironment in sporadic and
NF2
NF2-related schwannomatosis
tumour microenvironment
tumour-associated macrophages
vestibular schwannoma
Journal
Brain communications
ISSN: 2632-1297
Titre abrégé: Brain Commun
Pays: England
ID NLM: 101755125
Informations de publication
Date de publication:
2023
2023
Historique:
received:
13
04
2023
revised:
06
06
2023
accepted:
17
07
2023
medline:
8
9
2023
pubmed:
8
9
2023
entrez:
8
9
2023
Statut:
epublish
Résumé
Bilateral vestibular schwannoma is the hallmark of
Identifiants
pubmed: 37680691
doi: 10.1093/braincomms/fcad197
pii: fcad197
pmc: PMC10481781
doi:
Types de publication
Journal Article
Langues
eng
Pagination
fcad197Informations de copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of the Guarantors of Brain.
Déclaration de conflit d'intérêts
The authors report no competing interests.
Références
Neurooncol Adv. 2023 Jun 03;5(Suppl 1):i94-i104
pubmed: 37287576
Oncogene. 2010 Nov 25;29(47):6216-21
pubmed: 20729918
PLoS One. 2014 Dec 23;9(12):e115400
pubmed: 25536222
Vavilovskii Zhurnal Genet Selektsii. 2022 Feb;26(1):14-21
pubmed: 35342854
Development. 2012 Apr;139(7):1359-67
pubmed: 22357929
Histol Histopathol. 1990 Oct;5(4):427-32
pubmed: 2134396
Neuro Oncol. 2019 Feb 19;21(3):314-325
pubmed: 30388263
Neurooncol Adv. 2020 Feb 27;2(1):vdaa023
pubmed: 32642684
JAMA Neurol. 2017 Sep 1;74(9):1123-1129
pubmed: 28759666
Cancer Cell. 2014 Jun 16;25(6):846-59
pubmed: 24898549
Otol Neurotol. 2013 Sep;34(7):1355-61
pubmed: 23921927
J Neuropathol Exp Neurol. 1993 Mar;52(2):106-13
pubmed: 8440992
Virchows Arch. 2012 Jun;460(6):629-36
pubmed: 22555941
Neurooncol Adv. 2020 Nov 16;3(1):vdaa153
pubmed: 33604573
Proc Natl Acad Sci U S A. 2018 Feb 27;115(9):E2077-E2084
pubmed: 29440379
Int J Mol Sci. 2022 May 13;23(10):
pubmed: 35628268
J Transl Med. 2022 Nov 12;20(1):527
pubmed: 36371231
J Med Genet. 2021 Apr;58(4):227-233
pubmed: 32576656
Mol Med Rep. 2015 Jul;12(1):737-45
pubmed: 25738867
Otol Neurotol. 2013 Feb;34(2):347-52
pubmed: 23295727
Cancers (Basel). 2020 Jan 10;12(1):
pubmed: 31936793
Hear Res. 2019 Sep 15;381:107770
pubmed: 31430634
Front Neurol. 2020 Aug 14;11:796
pubmed: 33013614
J Neurol Surg B Skull Base. 2020 Sep 10;83(1):1-10
pubmed: 35155063
Cancer Immunol Res. 2022 Apr 1;10(4):403-419
pubmed: 35181780
Otol Neurotol. 2016 Jun;37(5):580-5
pubmed: 27093024
Nat Methods. 2015 May;12(5):453-7
pubmed: 25822800
Genome Biol. 2018 Feb 6;19(1):15
pubmed: 29409532
Nat Methods. 2019 Dec;16(12):1226-1232
pubmed: 31570887
Am J Pathol. 2022 Sep;192(9):1230-1249
pubmed: 35750260
Nat Rev Cancer. 2020 Sep;20(9):485-503
pubmed: 32694624
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Oncol Rep. 2014 Dec;32(6):2327-34
pubmed: 25333347
Neurosurgery. 2023 Mar 1;92(3):581-589
pubmed: 36729787
ACS Omega. 2021 Aug 13;6(33):21241-21254
pubmed: 34471729
Science. 2020 May 29;368(6494):
pubmed: 32299851
Acta Otolaryngol. 2000 Oct;120(8):950-4
pubmed: 11200590
JCI Insight. 2022 Jun 8;7(11):
pubmed: 35503656
J Immunother Cancer. 2019 Feb 26;7(1):54
pubmed: 30808413
J Neurooncol. 2020 Jan;146(2):265-273
pubmed: 31897926
Acta Neuropathol Commun. 2019 Jul 11;7(1):105
pubmed: 31291992
Front Oncol. 2022 Mar 15;12:836504
pubmed: 35372070
J Neurosurg. 2020 May 29;134(5):1419-1429
pubmed: 32470937
Virchows Arch. 2019 Mar;474(3):375-381
pubmed: 30580386
Genome Med. 2021 Jul 9;13(1):111
pubmed: 34238352
Lab Invest. 2017 May;97(5):498-518
pubmed: 28287634
Methods Mol Biol. 2018;1711:243-259
pubmed: 29344893
Nat Genet. 2016 Nov;48(11):1339-1348
pubmed: 27723760
N Engl J Med. 2009 Jul 23;361(4):358-67
pubmed: 19587327
Clin Immunol. 2023 Apr;249:109287
pubmed: 36907540
Adv Drug Deliv Rev. 2019 Jun;146:97-125
pubmed: 30267742
Orphanet J Rare Dis. 2009 Jun 19;4:16
pubmed: 19545378
J Laryngol Otol. 2010 Jul;124(7):720-8
pubmed: 20219149
Methods Mol Biol. 2020;2117:135-157
pubmed: 31960376
J Neurooncol. 2018 May;138(1):183-190
pubmed: 29427150
OTO Open. 2021 Nov 23;5(4):2473974X211059111
pubmed: 34870062
Genet Med. 2020 Jan;22(1):53-59
pubmed: 31273341